Select Equity Group, L.P. Eli Lilly & CO Put Options Transaction History

Select Equity Group, L.P.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $154,428 - $192,004	200 Added 2.56%	8,000 $7.09 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $1.23 Million - $1.55 Million	-1,700 Reduced 17.89%	7,800 $7.06 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $5.63 Million - $7.53 Million	9,500 New	9,500 $7.39 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Select Equity Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Select Equity Group, L.P. with notifications on news.